Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Grand Shuyang Life Sciences (chengdu) Co., Ltd.

Clinical trials sponsored by Grand Shuyang Life Sciences (chengdu) Co., Ltd., explained in plain language.

Trials to join now! 1

New IVIG trial hopes to boost platelets in bleeding disorder

Disease control Recruiting now

This study tests a medicine called human immunoglobulin (IVIG) given through a vein for 5 days in a row. It aims to raise platelet counts and reduce bleeding in adults with chronic immune thrombocytopenia (ITP), a condition where the immune system destroys platelets. About 36 par…

Phase: PHASE3 • Sponsor: Grand Shuyang Life Sciences (Chengdu) Co., Ltd. • Aim: Disease control

Last updated May 15, 2026 11:55 UTC